Intravenous gene therapy for familial hypercholesterolemia using ligand-facilitated transfer of a liposome:LDL receptor gene complex.
about
Cardiovascular gene therapy for myocardial infarctionGene therapy for lipoprotein disorders.Protein kinase C activation stabilizes LDL receptor mRNA via the JNK pathway in HepG2 cells.Gene therapy for heart disease: molecular targets, vectors and modes of delivery to myocardium.Novel Approaches for the Treatment of Familial Hypercholesterolemia: Current Status and Future Challenges
P2860
Intravenous gene therapy for familial hypercholesterolemia using ligand-facilitated transfer of a liposome:LDL receptor gene complex.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Intravenous gene therapy for f ...... ome:LDL receptor gene complex.
@en
Intravenous gene therapy for f ...... ome:LDL receptor gene complex.
@nl
type
label
Intravenous gene therapy for f ...... ome:LDL receptor gene complex.
@en
Intravenous gene therapy for f ...... ome:LDL receptor gene complex.
@nl
prefLabel
Intravenous gene therapy for f ...... ome:LDL receptor gene complex.
@en
Intravenous gene therapy for f ...... ome:LDL receptor gene complex.
@nl
P2093
P2860
P356
P1433
P1476
Intravenous gene therapy for f ...... ome:LDL receptor gene complex.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.GT.3301953
P577
2003-05-01T00:00:00Z
P5875
P6179
1008525255